Clinical Trials Directory

Trials / Completed

CompletedNCT07195565

Association of Continuous Renal Replacement Therapy With Mortality and Length of Stay in Critically Burned Patients

The Relationship Between Continuous Renal Replacement Therapy, Mortality, and Hospital Length of Stay in Critically Ill Burn Patients

Status
Completed
Phase
Study type
Observational
Enrollment
238 (actual)
Sponsor
Pinar Timur Tasci · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This retrospective observational study aims to investigate the clinical outcomes of critically ill burn patients who underwent continuous renal replacement therapy (CRRT). Primary endpoints include the evaluation of RIFLE criteria, timing of CRRT initiation, and overall survival. Secondary endpoints consist of comorbidity status, requirement for mechanical ventilation, inotropic support, and hospital length of stay among non-survivors.

Detailed description

Severe burn injury is frequently complicated by acute kidney injury (AKI), which is associated with high morbidity and mortality in intensive care settings. Continuous renal replacement therapy (CRRT) is often required in this patient population; however, the prognostic factors influencing survival remain incompletely defined. In this retrospective study, we analyzed critically ill burn patients who required CRRT. The primary outcomes were the RIFLE classification at the time of CRRT initiation, the timing of therapy initiation, and patient survival. The secondary outcomes included the presence of comorbidities, the need for mechanical ventilation, inotropic support, and length of hospital stay in non-survivors. By systematically evaluating these clinical parameters, the study aims to clarify the prognostic impact of CRRT in burn patients and to contribute evidence for optimizing the management of acute kidney injury in this critically ill population.

Conditions

Timeline

Start date
2021-01-01
Primary completion
2024-01-01
Completion
2024-01-01
First posted
2025-09-26
Last updated
2025-09-26

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07195565. Inclusion in this directory is not an endorsement.